FDA targets foreign tobacco oversight

On June 26, 2026, the U.S. Food and Drug Administration proposed a rule that would broaden regulatory requirements for tobacco products sold in the United States. The rule would cover companies that manufacture, prepare or process tobacco products, extending obligations that already apply to U.S. firms to foreign manufacturers whose products are shipped into the country.

Under the proposal, foreign manufacturers of tobacco products would be required to register their manufacturing establishments with the FDA. These registrations would need to be kept current and would sit alongside similar requirements for domestic producers, placing all companies selling tobacco products in the U.S. under a unified framework.

The proposed rule would require establishment registrations to be updated annually through the FDA’s online system. In addition, manufacturers would have to submit tobacco product listings twice a year, ensuring the agency has up-to-date information on products entering or being sold in the U.S. market.

For each listed product, companies would need to provide detailed identifying information. This includes nicotine concentration, the source of nicotine, characterizing flavors, package types and product dimensions. The goal is to create a consistent, structured dataset covering the range of tobacco products available to U.S. consumers.

The proposal includes additional reporting requirements for e-cigarettes, reflecting their technical complexity. Manufacturers of these products would have to specify e-liquid volume, battery capacity and wattage, alongside the core information required for other tobacco products.

By collecting these technical specifications, the FDA seeks to gain a clearer view of the electronic nicotine delivery systems present in the U.S. market. This information is intended to support the agency’s broader regulatory oversight of e-cigarette designs and performance characteristics.

Manufacturers covered by the proposed rule would be required to maintain records of labeling, advertising and consumer information for at least four years. These records would be subject to FDA review, helping the agency monitor how products are marketed and presented to consumers over time.

The FDA states that the rule is intended to strengthen its ability to identify and take action against illegal foreign tobacco products. This includes unauthorized disposable e-cigarettes that are popular with youth and that may evade current controls at the border or in retail channels. The rule would also support inspections of foreign facilities that manufacture tobacco products for the U.S. market.

The proposal could affect major global tobacco companies whose products are shipped into the United States, including British American Tobacco (BATS.L), Japan Tobacco and Imperial Brands, as well as smaller overseas e-cigarette manufacturers.

Public comment on the proposed rule is open through September 14, 2026, giving stakeholders time to respond to the planned requirements. The acting director of the FDA’s Center for Tobacco Products has emphasized that all companies selling tobacco products in the United States should be subject to the same rules, reflecting the agency’s push toward consistent regulatory treatment across the industry.